Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: A systematic review

Heart Failure Reviews

Volumn 19, Issue 4, 2014, Pages 521-540

  Don Wauchope, Andrew C ^a   Santaguida, Pasqualina L ^a   Oremus, Mark ^a   McKelvie, Robert ^a   Ali, Usman ^a   Brown, Judy A ^a   Bustamam, Amy ^a   Sohel, Nazmul ^a   Hill, Stephen A ^a   Booth, Ronald A ^b   Balion, Cynthia ^a   Raina, Parminder ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Incremental predictive value; NT proBNP; Systematic review

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; NATRIURETIC FACTOR;

ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; HEART FAILURE; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROTEIN DETERMINATION; RISK ASSESSMENT; SYSTEMATIC REVIEW; BLOOD; HEALTH; HEALTH SURVEY; SURVIVAL RATE;

BIOLOGICAL MARKERS; GLOBAL HEALTH; HEART FAILURE; HUMANS; MORBIDITY; NATRIURETIC PEPTIDES; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE;

EID: 84906355714     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-014-9443-x     Document Type: Article

References (25)

1. Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P (2006) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Rockville, MD: AHRQ; 2006. AHRQ publication no. 06-E014. Available at: PM:17764210
2. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D et al (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circ Cardiovasc Qual Outcomes 120:2177-2187. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.884866
3. Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330:625. http://dx.doi.org/10.1136/bmj.330.7492. 62
4. Vesbianu D, Vesbianu C, Bernstein P, Kouides R (2008) Plasma brain natriuretic peptide - an independent predictor of mortality and rehospitalization in congestive heart failure - a meta-analysis. World Heart J 1:349-354
5. Oremus M, Raina PS, Santaguida P, Balion CM, McQueen MJ, McKelvie R et al (2008) A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem 41:260-265. http://dx.doi.org/10.1016/j. clinbiochem.2007.09.011 (Pubitemid 351240898)
6. Balion C, Don-Wauchope A, Hill S, Santaguida PL, Booth R, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Raina P (2013) Use of natriuretic peptide measurement in the management of heart failure. Comparative effectiveness reviews, no. 126. 2013. AHRQ publication no. 13(14)-EHC118-EF. www.effectivehealthcare.ahrq.gov/reports/final.cfm
7. Hayden JA, Côté P, Steenstra IA, Bombardier C, QUIPS-LBP Working Group (2008) Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies. J Clin Epidemiol 61:552-560. http://dx.doi.org/10.1016/j.jclinepi.2007.08.005
8. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS et al (2009) Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circ Cardiovasc Qual Outcomes 119:2408-2416. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192278
9. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) (2012) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 33:1750-1757. doi:10.1093/eurheartj/ehr254
10. Mikkelsen KV, Møller JE, Bie P, Ryde H, Videbaek L, Haghfelt T (2006) Tei index and neurohormonal activation in patients with incident heart failure: serial changes and prognostic value. Eur J Heart Fail 8:599-608. http://dx.doi.org/10.1016/j.ejheart.2005.11.015 (Pubitemid 44574542)
11. Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR (2007) Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. Am J Cardiol 100:1571-1576. http://dx.doi.org/10.1016/j.amjcard.2007.06.064 (Pubitemid 350050866)
12. Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S et al (2006) Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52:1528-1538. http://dx.doi.org/10.1373/clinchem.2006.069575 (Pubitemid 44148316)
13. Dini FL, Rosa GM, Fontanive P, Santonato V, Napoli AM, Ciuti M et al (2010) Combining blood flow and tissue Doppler imaging with N-terminal pro-type B natriuretic peptide for risk stratification of clinically stable patients with systolic heart failure. Eur J Echocardiogr 11:333-340. http://dx.doi.org/10. 1093/ejechocard/jep207
14. Dini FL, Fontanive P, Buralli S, Panicucci E, Andreini D, Conti U et al (2009) N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure. Int J Cardiol 136:144-150. http://dx.doi.org/10.1016/j. ijcard.2008.04.032
15. Dini FL, Conti U, Fontanive P, Andreini D, Panicucci E, De Tommasi SM (2008) Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy. Am J Cardiol 102:463-468. http://dx.doi.org/10. 1016/j.amjcard.2008.03.083
16. Dini FL, Fontanive P, Panicucci E, Andreini D, Chella P, De Tommasi SM (2008) Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation. Eur J Heart Fail 10:573-580. http://dx.doi.org/10.1016/j.ejheart. 2008.04.003
17. Bajraktari G, Dini FL, Fontanive P, Elezi S, Berisha V, Napoli AM et al (2011) Independent and incremental prognostic value of Doppler-derived left ventricular total isovolumic time in patients with systolic heart failure. Int J Cardiol 148:271-275. http://dx.doi.org/10.1016/j.ijcard.2009.09.567
18. Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C et al (2009) Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 54:1850-1859. http://dx.doi.org/10.1016/j.jacc.2009.06.041
19. Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH et al (2009) Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail 11:281-291. http://dx.doi.org/10. 1093/eurjhf/hfn046
20. Jankowska EA, Filippatos GS, von HS, Papassotiriou J, Morgenthaler NG, Cicoira M et al (2011) Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. PLoS ONE 6:e14506. http://dx.doi.org/10.1371/journal.pone. 0014506
21. von Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W et al (2010) Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 12:484-491. http://dx.doi.org/10.1093/eurjhf/hfq031
22. Bayes-Genis A, de Antonio M, Galán A, Sanz H, Urrutia A, Cabanes R et al (2012) Combined use of high-sensitivity ST2 and NT-proBNP to improve the prediction of death in heart failure. Eur J Heart Fail 14:32-38. http://dx.doi.org/10.1093/eurjhf/hfr156
23. de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A (2012) Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. Am Heart J 163:821-828. http://dx.doi.org/10.1016/j.ahj.2012.03.004
24. Christensen HM, Frystyk J, Faber J, Schou M, Flyvbjerg A, Hildebrandt P et al (2012) A-defensins and outcome in patients with chronic heart failure. Eur J Heart Fail 14:387-394. http://dx.doi.org/10.1093/eurjhf/hfs021
25. Alba AC, Agoritsas T, Jankowski M, Courvoisier D, Walter SD, Guyatt GH et al (2013) Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail 6:881-889. doi:10.1161/CIRCHEARTFAILURE.112.000043